GNQ-80031-51514
3 vaccinations
2 coded responses
12 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 840 / UT
- Registered
- 2022-06-20
- Relationship
- Child or adolescent in my care
- Guardian
- NCK-26679-96251
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-20
Registered in v-safe
-
2022-06-24
Dose 1 — Pfizer-BioNTech
-
2022-07-19
Dose 2 — Pfizer-BioNTech
-
2022-10-06
Dose 3 — Pfizer-BioNTech
- 2022-10-07
- 2022-10-09
- 2022-10-10
- 2022-10-12
-
2022-10-15
Survey response — day 7, dose 3, under 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Good · FeverFree text: Runny nose/congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-20
- 2022-10-27
-
2022-11-05
Survey response — day 28, dose 3, under 3MedDRA: Anaphylaxis treatment, Decreased appetite, Fatigue, Hypersensitivity, Office visit, Pyrexia — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Allergic reaction last week requiring epi. New vaccines given at pediatricians office (prevnar, mmr, Hep A and Flu) which caused symptoms of fever and fatigue and loss of appetite.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-05
Report sent to call center — day 28, dose 3, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-11-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-10
- 2022-11-17
- 2023-01-05
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Pfizer-BioNTech | No |
| 2 | 2022-07-19 | Pfizer-BioNTech | No |
| 3 | 2022-10-06 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — day 7, dose 3, under 3
Systemic reaction (other): Runny nose/congestion
Release 12 (Under 3) — day 28, dose 3, under 3
Symptoms: Allergic reaction last week requiring epi. New vaccines given at pediatricians office (prevnar, mmr, Hep A and Flu) which caused symptoms of fever and fatigue and loss of appetite.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anaphylaxis treatment | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release